Coronary Artery Disease

ACCP Coronary Artery Disease

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/86166

Contents of this Issue

Navigation

Page 8 of 9

Coronary Artery Disease After ACS STE ≤ 12 months (2B) × 2-4 weeks (1A) NSTE Stents PCI BMS × 12 mos. (1A) (1A: 3-4 mos; 1B: 4-12 mos.) × 3-12 mos. NSTEMI (2B) For × 9-12 mos. (2B) and post-op (2A) Indefinitely (1A) Clopidogrel† 75 mg qd 75-100 mg qd Aspirin aspirin intolerance (1B) Clopidogrel† for †FDA warning: Clopidogrel (Plavix) can be less effective in poor metabolizers. 75-162 mg qd indefinitely (1A) Aspirin initially and 75-100 mg qd indefinitely (1A) Aspirin 75-162 mg DES CABG bypass IMA With or without STE

Articles in this issue

Archives of this issue

view archives of Coronary Artery Disease - ACCP Coronary Artery Disease